Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Human Lifespan May Have Reached Natural Constraints

By HospiMedica International staff writers
Posted on 18 Oct 2016
A new study suggests that improvements in survival tend to decline after age 100, and that the age at death of the world’s oldest person has not increased since the 1990s.

Researchers at Albert Einstein College of Medicine (New York, NY, USA) analyzed global demographic data from the Human Mortality Database, which compiles mortality and population data from more than 40 countries. More...
They focused on people verified as living to age 110 or older in four countries--The United States, France, Japan, and the United Kingdom--with the largest number of long-lived individuals. In all four countries, the fraction of each year’s birth cohort (since 1900) who survived to old age increased, pointing toward a continuing increase in average life expectancy.

The researchers found that while super-centenarian lifespan increased rapidly between the 1970s and 1990s, it reached a plateau in 1997 with the death of 122-year-old Jeanne Calment, the longest documented lifespan in history. Using maximum-reported-age-at-death data, the researchers estimated the average maximum human life span at 115 years, considering Jeanne Calment a statistical outlier. Finally, the researchers calculated that 125 years is the absolute limit of human lifespan. The study was published on October 5, 2016, in Nature.

“Demographers as well as biologists have contended there is no reason to think that the ongoing increase in maximum lifespan will end soon, but our data strongly suggest that it has already been attained, and that this happened in the 1990s,” said senior author professor of molecular genetics Jan Vijg, PhD. “Further progress against infectious and chronic diseases may continue boosting average life expectancy, but not maximum lifespan.”

“While it's conceivable that therapeutic breakthroughs might extend human longevity beyond the limits we've calculated, such advances would need to overwhelm the many genetic variants that appear to collectively determine the human lifespan,” concluded Professor Vijg. “Perhaps resources now being spent to increase lifespan should instead go to lengthening health span - the duration of old age spent in good health.”

Since the 19th century, average life expectancy has risen almost continuously thanks to improvements in public health, diet, the environment, and other areas. On average, for example, babies born today in the U.S. can expect to live nearly until age 79, compared with an average life expectancy of only 47 in 1900. Together with observations that lifespan in various animal species is flexible, and can be increased by genetic or pharmaceutical intervention, these demographics led to suggestions that longevity may not be subject to strict, species-specific genetic constraints.

Related Links:
Albert Einstein College of Medicine


Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Endoscopy Display
E190
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.